Price T Rowe Associates Inc Otonomy, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
BUY
$1.22 - $2.2 $24,400 - $44,000
20,000 Added 48.31%
61,400 $118,000
Q2 2021

Aug 16, 2021
BUY
$2.06 - $2.67 $40,582 - $52,599
19,700 Added 90.78%
41,400 $92,000
Q4 2020

Feb 16, 2021
BUY
$3.48 - $6.47 $75,516 - $140,399
21,700 New
21,700 $140,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email